Laurion Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-524	Closed	-$373K	–	387
2024 Q4	$373K	Buy	+524	New	+$440K	0.02%	235
2022 Q2	–	Sell	-10,000	Closed	-$6.98M	–	671
2022 Q1	$6.98M	Buy	+10,000	New	+$6.33M	0.17%	141
2021 Q3	–	Sell	-443	Closed	-$247K	–	863
2021 Q2	$247K	Buy	+443	New	+$224K	﹤0.01%	626
2021 Q1	–	Sell	-427	Closed	-$206K	–	897
2020 Q4	$206K	Buy	+427	New	+$230K	0.01%	583
2020 Q2	–	Hold	0	–	–	–	1148
2020 Q1	–	Hold	0	–	–	–	1081
2019 Q4	–	Sell	-200	Closed	-$55K	–	1235
2019 Q3	$55K	Sell	200 -4,452	-96%	-$1.32M	﹤0.01%	960
2019 Q2	$1.46M	Buy	+4,652	New	+$1.55M	0.07%	501
2019 Q1	–	Sell	-4,285	Closed	-$1.76M	–	1250
2018 Q4	$1.6M	Buy	4,285 +20	+0.5%	+$7.32K	0.08%	469
2018 Q3	$1.72M	Sell	4,265 -3,913	-48%	-$1.49M	0.06%	569
2018 Q2	$2.82M	Hold	8,178	–	–	0.07%	505
2018 Q1	$2.82M	Buy	8,178 +600	+8%	+$209K	0.07%	536
2017 Q4	$2.85M	Buy	7,578 +2,900	+62%	+$1.17M	0.05%	675
2017 Q3	$2.09M	Sell	4,678 -500	-10%	-$238K	0.04%	760
2017 Q2	$2.54M	Buy	5,178 +1,520	+42%	+$665K	0.06%	746
2017 Q1	$1.42M	Buy	3,658 +1,758	+93%	+$652K	0.04%	673
2016 Q4	$697K	Buy	+1,900	New	+$723K	0.03%	771